Dermavant Sciences Ltd.
We are a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology. We have a robust medical dermatology pipeline with both late-stage and early-development product candidates. Our pipeline targets specific unmet needs in two of the largest growing immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne.
|Address||Suite 1, 3rd Floor, 11-12 St. James’s Square, London SW1Y 4LB, United Kingdom|
|Phone Number||+44 (117) 918-1293|
|View Prospectus:||Dermavant Sciences Ltd.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$-255.3 mil (last 12 months)|
|Price range||$12.00 - $14.00|
|Est. $ Volume||$100.1 mil|
|Manager / Joint Managers||Jefferies/ SVB Leerink/ Guggenheim Securities|
|Expected To Trade:||6/20/2019|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|